The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, XPeng Inc ADR (NYSE: XPEV) closed at $21.02 down -4.06% from its previous closing price of $21.91. In other words, the price has decreased by -$4.06 from its previous closing price. On the day, 9.99 million shares were traded. XPEV stock price reached its highest trading level at $21.7 during the session, while it also had its lowest trading level at $20.875.
Ratios:
For a deeper understanding of XPeng Inc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.01 whereas as Long-Term Debt/Eq ratio is at 0.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BNP Paribas Exane on August 18, 2025, initiated with a Neutral rating and assigned the stock a target price of $19.
On June 17, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $16.40 to $24.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 18 ’24 when GGV (XPENG) LTD bought 303,680 shares for $12.71 per share.
GGV (XPENG) LTD bought 303,681 shares of XPEV for $3,897,472 on Dec 17 ’24. On Sep 04 ’24, another insider, GGV (XPENG) LTD, who serves as the Affiliate of the company, bought 408,506 shares for $8.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XPEV now has a Market Capitalization of 20480479232 and an Enterprise Value of 21986232320. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.96 while its Price-to-Book (P/B) ratio in mrq is 4.72. Its current Enterprise Value per Revenue stands at 0.365 whereas that against EBITDA is -7.52.
Stock Price History:
The Beta on a monthly basis for XPEV is 2.51, which has changed by 1.5113502 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, XPEV has reached a high of $27.16, while it has fallen to a 52-week low of $7.47. The 50-Day Moving Average of the stock is 8.52%, while the 200-Day Moving Average is calculated to be 17.67%.
Shares Statistics:
For the past three months, XPEV has traded an average of 7.55M shares per day and 14269250 over the past ten days. A total of 776.89M shares are outstanding, with a floating share count of 759.35M. Insiders hold about 2.27% of the company’s shares, while institutions hold 14.22% stake in the company. Shares short for XPEV as of 1755216000 were 41568248 with a Short Ratio of 5.51, compared to 1752537600 on 37142725. Therefore, it implies a Short% of Shares Outstanding of 41568248 and a Short% of Float of 5.510000000000001.
Earnings Estimates
Currently, 3.0 analysts are dedicated to thoroughly evaluating and rating the performance of XPeng Inc ADR (XPEV) in the stock market.The consensus estimate for the next quarter is $0.51, with high estimates of $0.76 and low estimates of $0.07.
Analysts are recommending an EPS of between -$0.4 and -$1.37 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is $2.23, with 7.0 analysts recommending between $3.99 and $0.73.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $20.52B this quarter.It ranges from a high estimate of $21.19B to a low estimate of $19.77B. As of the current estimate, XPeng Inc ADR’s year-ago sales were $10.1BFor the next quarter, 8 analysts are estimating revenue of $24.88B. There is a high estimate of $27.21B for the next quarter, whereas the lowest estimate is $17.76B.
A total of 28 analysts have provided revenue estimates for XPEV’s current fiscal year. The highest revenue estimate was $89.18B, while the lowest revenue estimate was $71.13B, resulting in an average revenue estimate of $79.83B. In the same quarter a year ago, actual revenue was $40.87BBased on 37 analysts’ estimates, the company’s revenue will be $114.28B in the next fiscal year. The high estimate is $150.79B and the low estimate is $87.22B.
